PW Medtech Group Limited (HKG:1358)

PW Medtech Group Revenue

PW Medtech Group had revenue of 394.06M CNY in the half year ending June 30, 2026, with 16.44% growth. This brings the company's total for the last twelve months to 803.19M, down -4.93% year-over-year. In the year 2025, PW Medtech Group had annual revenue of 823.51M with 7.10% growth. That makes PW Medtech Group the 21,374th largest company in the world by revenue and 1,251st in Hong Kong.

• Revenue (ttm): 803.19M CNY
• Revenue Growth: -4.93%
• P/S Ratio: 1.38
• Revenue / Employee: 560.49K CNY
• Employees: 1,433
• Market Cap: 1.28B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Blood Purification 611.79M 74.3%
• Infusion Set 207.64M 25.2%
• Regenerative Medical Biomaterials 4.07M 0.5%

By Geography

Chart

• China 635.96M 77.2%
• Other Asia Countries 65.03M 7.9%
• India 55.95M 6.8%
• Africa Region 29.27M 3.6%
• America(Excluding U.S) 26.45M 3.2%
• Others 10.85M 1.3%

Fiscal year ended Dec 31, 2025 See the full PW Medtech Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	823.51M	54.60M	7.10%
Dec 31, 2024	768.90M	93.82M	13.90%
Dec 31, 2023	675.08M	138.26M	25.75%
Dec 31, 2022	536.83M	265.43M	97.80%
Dec 31, 2021	271.40M	24.05M	9.72%

Data Source: S&P Global Market Intelligence Last updated: Sep 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 18, 2026

Data Sources Report a data error